openPR Logo
Press release

High Altitude Platforms Market - Segment Accounted for the Largest Share of Around 38%

02-09-2017 10:08 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

High Altitude Platforms Market - Segment Accounted for

High altitude platforms (HAPs) are objects stationed at a height of more than 50,000 feet from Earth’s surface. HAPs are commonly deployed in the stratospheric layer, far higher than the altitude at which commercial aircraft operate. Thus, HAPs are capable of covering large surface areas and can be used for maritime and land-based applications.

These platforms are used for various applications, such as communication systems, persistent surveillance, and navigation. Apart from these, HAPs are also used for applications such as aerial imaging, environmental monitoring, and Internet services. HAPs are often referred to as alternatives to satellite systems due to their capacity of fulfilling similar purposes.

The most significant factor augmenting the HAP market’s growth is their competitive advantage over satellite systems. HAPs require much lower expenses for system deployment and operation than satellite systems.

Additionally, the payloads attached to HAPs are also compatible with the existing infrastructure, which makes them preferable to satellite systems. These systems have shorter turn-around times than satellite systems due to their proximity to Earth’s surface in comparison with satellites.

Furthermore, the market for HAPs is significantly driven by the increasing defense expenditure of major countries worldwide. Government & defense is the largest segment of this market in terms of revenue and adoption. Thus, growing expenditure on surveillance systems is expected to significantly spur the market’s growth in the coming years.

The market for HAPs is also driven by the growing penetration of Internet services worldwide. HAPs are increasingly being used to deliver wireless Internet services, which are further expected to witness substantial growth in the coming years.

Request A Sample Of This Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1282

One of the most prominent instances is Project Loon by Google, Inc., which aims to provide Internet services through aerostat systems (balloons) deployed in the stratosphere. Nevertheless, the HAPs market faces some of the challenges related to the costs and operational difficulties.

Although much less so than the market for satellite systems, the market for HAPs is significantly hampered by the high initial and operating costs of UAV aircraft.

This makes these systems inaccessible to countries with low defense budgets. Furthermore, aerostat systems and airships pose operational challenges such as extremely slow deployment, difficult handling, and restriction on payload weight.

The global HAPs market is segmented into type of platforms, payload, application, and geographic regions. On the basis of platform type, the market is segmented into airships, UAV aircraft, and tethered aerostat systems. In 2014, the UAV aircraft segment accounted for the largest share, in terms of revenue, of the global HAPs market.

This was due to high cost of the aircraft (resulting in higher revenue per unit) coupled with strong adoption from countries such as the U.S., China, Russia, and France. However, the tethered aerostat systems segment is estimated to witness high demand during the forecast period because of advantages that include low costs, easy upgrading, and low maintenance offered by these platforms over UAV aircrafts.

On the basis of payloads, the global HAPs market is segmented into communication, surveillance systems, EO/IR systems, and navigation. The global market for HAPs was dominated by the communication segment in 2014.

Communication is the most integral payload, making it the largest segment globally. Furthermore, the communication segment is predicted to hold its dominant position throughout the forecast period due to ongoing prospects for HAP-based wireless communication across different regions.

About TMR

TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact TMR

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website:http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release High Altitude Platforms Market - Segment Accounted for the Largest Share of Around 38% here

News-ID: 433840 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for HAP

Hydroxyapatite Hap Market Trends 2021 | Segmentation, Outlook, Industry Report t …
The Hydroxyapatite Hap Market size is expected to grow at an annual average of 5% during 2021-2027. Hydroxyapatite (HA) is a major component of normal bone and teeth already used as a coating for orthopedic implants to anchor and promote bone growth. Growing demand for dental and orthopedic implants along with growing popularity of bioactive materials and strong investment in R&D activities to expand the application of hydroxyapatite are expected
Hydroxyapatite (HAp) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Hydroxyapatite (HAp) analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Hydroxyapatite (HAp) 2020-2025” Research Report categorizes the global Hydroxyapatite (HAp) by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities
Hydroxyapatite Hap Market, Industry Share, Trends, Growth, Future Prospects, For …
The Hydroxyapatite (HAp) market is expected to grow by 6.5% CAGR from 2019 to 2025, growing from $2.2 billion in 2019 to $3.1 billion in 2025. Hydroxyapatite (HAp) is a mineral present in the bones and hard tissues of humans and animals. The micro-sized hydroxyapatite (HAp) can be designed using nanotechnology applicable to orthopedic surgery and drug delivery systems. It is mainly used for various bone graft methods, and is also
Global Hospital-Acquired Pneumonia (HAP) Drugs Market 2019 - Teva Pharmaceutical …
HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects the microscopic air sacs called alveoli. This is primarily caused by infection by bacteria or viruses and sometimes with other microorganisms.
Hydroxyapatite Market (HAp) 2018 Global Industry Trends, Share, Size and 2023 Fo …
2018-2023 Hydroxyapatite Market (HAp) research report presents a comprehensive study of the Hydroxyapatite Market in Global Industry; the study scans the progression of the market trailed over the past few years and the forecasts of growth in the coming years, primarily in terms of sales. The research report highlights the reasons liable for the disparities in the market and investigates them methodically. The Hydroxyapatite Market (HAp) effect factors have also
Global Hospital-acquired Pneumonia (HAP) Drugs Market Outlook 2017-2021
The study of Hospital-acquired Pneumonia (HAP) Drugs Market in UK 2017-2021 industry is very important to enhance business productivity and for the study of market forecast. This New Report presented by Orbis Reseach contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Hospital-acquired Pneumonia (HAP) Drugs is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of